FibroBiologics 获得了美国专利商标局颁发的三项专利，涉及软骨修复、椎间盘退行性疾病治疗和软骨细胞再生。 FibroBiologics received three patents from the USPTO for cartilage repair, disc degenerative disease treatment, and chondrocyte regeneration.
总部位于休斯敦的临床阶段生物技术公司 FibroBiologics 宣布获得美国专利局授予的三项专利，扩大了其产品组合，使已授予和正在申请的专利总数超过 150 项。 FibroBiologics, a Houston-based clinical-stage biotechnology company, announced the issuance of three patents from the US Patent Office, expanding its portfolio and taking the total number of issued and pending patents to over 150. 这些专利涵盖用于修复软骨、治疗椎间盘退行性疾病以及用于再生软骨细胞或软骨细胞的基因疗法的方法和组合物。 The patents cover methods and compositions for repairing cartilage, treating disc degenerative disease, and gene therapy for regenerating chondrocytes or cartilage cells.